Suzanne Dawn Turner

35PUBLICATIONS
130CO-AUTHORS
Tumour immunologyImmunogenetics (incl. genetic immunology)Molecular targetsSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Jul 14, 2026
Burkitt Lymphoma: Current Understanding, Unmet Needs, and Research Directions.

|Apr 02, 2025
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy.

Maša Zrimšek, Kristina Draganić, Anna Malzer

|Oct 31, 2024
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.

Matteo Villa, Geeta G Sharma, Federica Malighetti

|Apr 23, 2024
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Perla Pucci, Liam C Lee, Miaojun Han

|Sep 29, 2023
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.

Qian Zhang, Johnvesly Basappa, Hong Y Wang

Pageof 6

Frequent Collaborators

5 joint publications

Nina Prokoph

5 joint publications

Gladstone A A Burke

4 joint publications

Lukas Kenner

3 joint publications

Huan-Chang Liang